CBUS
Healthcare BiotechnologyCibus, Inc.
$1.71
+0.08 +4.91% today
Price History
Not enough data
Key Stats
Market Cap
130.69M
Avg Volume
238,301
EPS
-$1.57
52W High
$4.19
52W Low
$1.09
Div. Yield
0.0%
Analyst Ratings
Buy0
Str Buy
2
Buy
1
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
-2.69
P/B Ratio
8.81
P/S Ratio
30.07
EV/EBITDA
-8.11
EV/Revenue
91.22
Margins
Gross Margin 100.0%
Operating Margin (1300.3%)
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
6.5%
Return on Equity
(223.2%)
Return on Assets
(10.2%)
Liquidity & Leverage
Current Ratio
1.62
Quick Ratio
1.49
Debt / Equity
19.34
Total Cash
20.43M
Total Debt
286.26M
About
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
www.cibus.com